Диссертация (1139581), страница 47
Текст из файла (страница 47)
Gabexate for the prevention ofpancreatic damage related to endoscopic retrograde cholangiopancreatography.Gabexate in digestive endoscopy – Italian Group. N Engl J Med 1996; 335: 919–923.216. Cennamo V., Fuccio L., Repici A. et al. Timing of precut procedure does notinfluence success rate and complications of ERCP procedure: a prospectiverandomized comparative study. Gastrointest Endosc 2009; 69: 473–479.217. Cennamo V., Fuccio L., Zagari R.M. et al.
Can a wire-guided cannulationtechnique increase bile duct cannulation rate and prevent post-ERCP pancreatitis?:A meta-analysis of randomized controlled trials. Am J Gastroenterol 2009; 104:2343-2350.218. Chahal P., Tarnasky P., Petersen B. et al. Short 5Fr vs long 3Fr pancreaticstents in patients at high risk for post- endoscopic cholangiopancreatographypancreatitis. Clin Gastroenterol Hepatol 2009; 7: 834–839.219. Cheon Y.K., Cho K.B., Watkins J.L. et al. Frequency and severity of postERCP pancreatitis correlated with extent of pancreatic ductal opacification.Gastrointest Endosc 2007; 65: 385–393.220.
Cheung J., Tsoi K.K., Quan W.-L., Lau J.Y.W., Sung J.J.Y. Guidewireversus conventional contrast cannulation of the common bile duct for theprevention of post-ERCP pancreatitis: a systematic reviewand meta-analysis.Gastrointest Endosc 2009; 70: 1211-1219.221. Choi C.W., Kang D.H., Kim G.H. et al. Nafamostat mesylate in theprevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis.Gastrointest. Endosc. 2009; 69: 11-18.222.
Choudhary A., Puli S., Ibdah J., Bechtold M. Guidewire use for preventionof post ERCP pancreatitis: a meta-analysis of randomized controlled trials.Gastrointest Endosc 2009; 69: AB305.298223. Cotton P.B., Garrow D.A., Gallagher J., Romagnuolo J.: Risk factors forcomplications after ERCP: a multivariate analysis of 11,497 procedures over 12years. USA.: Gastrointest Endosc 2009; 70(1):80-88.224. Coulibaly F., Chevalier C., Delmas B., Rey F.A. Crystal structure of anaquabirnavirusparticle:Insightsintoantigenicdiversityandvirulencedeterminism.
J Virol 2010; 84: 1792-1799.225. Dai H.F., Wang X.W., Zhao K. Role of nonsteroidal anti-inflammatorydrugs in the prevention of post-ERCP pancreatitis: A meta-analysis. HepatobiliaryPancreat. Dis. Int. 2009; 8: 11-16.226. de Waele J.J., Lepp A.K. Intra-abdominal hypertension in acute pancreatitis.World Journal of Surgery 2009; 33(6): 1128-1133.227. Deviere J., Le Moine O., Van Laethem J.L. et al. Interleukin 10 reduces theincidenceofpancreatitisaftertherapeuticendoscopicretrogradecholangiopancreatography. Gastroenterology 2001; 120: 498–505.228. Dumonceau J-M, Andriulli A., Deviere J., Mariani A., Rigaux J., BaronT.H., Testoni P.A.: Guidelines: prophylaxis of post-ERCP pancreatitis. Endoscopy2010; 42:503-515.229.
Dumot J.A., Conwell D.L., Zuccaro G. Jr. et al. A randomized, double blindstudy of interleukin 10 for the prevention of ERCP-induced pancreatitis. Am JGastroenterol 2001; 96: 2098–2102.230. Duvnjak M., Supanc V., Simicevic V.N. et al. Use of octreotide-acetate inpreventing pancreatitis-like changes following therapeutic endoscopicretrogradecholangiopancreatography. Acta Med Croatica 1999; 53: 115–118.231.
Easler J.J., Papachristou G.I., Zureikat A. An update on minimally invasivetherapies for pancreatic necrosis. Expert Review of Gastroenterology andHepatology 2012; 6(6): 745-753.232. Elmunzer B.J., Waljee A.K., Elta G.H. et al. A metaanalysis of rectalNSAIDs in the prevention of post-ERCP pancreatitis.
Gut 2008; 57: 1262-1267.299233. Escobar J., Pereda J., L´opez-Rodas G., Sastre J. Redox signaling andhistone acetylation in acute pancreatitis. Free Radical Biology and Medicine 2012;52(5): 819-837.234. Evensen O., Santi N. Infectious pancreatic necrosis virus. In: Mahy BWJand van Regenmortel MVH(eds), editors. In encyclopedia of virology, 3 rd virologyedn. Elsevier: Oxford 2008: 83-89.235. Faigel D.O., Cotton P.B. London OMED guidelines for credentialing andquality assurance in digestive endoscopy. Endoscopy 2009; 41: 1069-1074.236. Forsmark C.E., Baillie J. AGA Institute technical review on acutepancreatitis.
Gastroenterology 2007; 132: 2022-2044.237. Freeman M.L., Nelson D.B., Sherman S. et al. Complications of endoscopicbiliary sphincterotomy. N Engl J Med 1996; 335: 909–918.238. Freeman, M.L. Prevention of post-ERCP pancreatitis: Pharmacologicsolution or patient selection and pancreatic stents? Gastroenterology 2003; 124:1977-1980.239. Fujishiro H., Adachi K., Imaoka T. et al.
Ulinastatin shows preventive effecton post-endoscopic retrograde cholangiopancreatography pancreatitis in amulticenter prospective randomized study. J Gastroenterol Hepatol 2006; 21:1065–1069.240. Garcea G., Gouda M., Hebbes C. et al. Predictors of severity and survival inacute pancreatitis: validation of the efficacy of early warning scores. Pancreas2008; 37(3): e54–e61.241. Gardner T.B., Chahal P., Papachristou G.I., Vege S.S., Petersen B.T.,Gostout C.J. et al. A comparison of direct endoscopic necrosectomy withtransmural endoscopic drainage for the treatment of walled-off pancreatic necrosis.Gastrointest Endosc 2009; 69: 1085-1094.242. Gorelick A., Barnett J., Chey W., Anderson M., Elta G.
Botulinum toxininjection after biliary sphincterotomy. Endoscopy 2004; 36: 170–173.300243. Gottlieb K., Sherman S., Pezzi J., Esber E., Lehman G.A. Early recognitionof post-ERCP pancreatitis by clinical assessment and serum pancreatic enzymes.Am J Gastroenterol 1996; 91: 1553–1557.244. Grasso D., Ropolo A., Lo R´e A.
et al. Zymophagy, a novel selectiveautophagy pathway mediated by VMP1-USP9xp62, prevents pancreatic cell death.The Journal of Biological Chemistry 2011; 286(10): 8308-8324.245. Gukovskaya A.S., Gukovsky I. Autophagy and pancreatitis. AmericanJournal of Physiology 2012; 303(9): 993-1003.246. Gukovsky I., Pandol S.J., Mareninova O.A., Shalbueva N., Jia W.,Gukovskaya A.S. Impaired autophagy and organellar dysfunction in pancreatitis.Journal of Gastroenterology and Hepatology 2012; 27(2): 27-32.247.
Guler O., Akturan S., Kisli E., Dolapci I., Caydere M., et al. Acutepancreatitis, bacterial translocation, and different octreotide regimens: anexperimental study. Surg Today 2009; 39: 876-883.248. Gultekin F.A., Kerem M., Tatlicioglu E., Aricioglu A., Unsal C., et al.Leptin treatment ameliorates acute lung injury in rats with cerulein-induced acutepancreatitis. World J Gastroenterol 2007; 13: 2932-2938.249. Gupta R., Lakhtakia S., Tandan M.
Recurrent Acute Pancreatitis andWirsungocele. A Case Report and Review of Literature. India: J Pancreas. – 2008;9(4): 531-533.250. Hardt P.D., Kress O., Fadgyas T. et al. Octreotide in the prevention ofpancreatic damage induced by endoscopic sphincterotomy. Eur J Med Res 2000; 5:165–170.251. Hegyi P., Rakonczay Z.Jr. The role of nitric oxide in the physiology andpathophysiology of the exocrine pancreas.
Antioxidants & Redox Signaling 2011;15: 2723-2741.252. Herreros de Tejada A., Calleja J.L., Díaz G. et al. Double-guidewiretechnique for difficult bile duct cannulation: a multicenter randomized, controlledtrial. Gastrointest Endosc 2009; 70: 700-709.301253. Hukkanen R.R., Liggitt H.D., Murnane R.D., Frevert C.W. Systemicinflammatory response syndrome in nonhuman primates culminating in multipleorgan failure, acute lung injury, and disseminated intravascular coagulation.Toxicol Pathol 2009; 37: 799-804.254. Hyare H., Desigan S., Brookes J.A., Guiney M.J., Lees W.R. Endovascularmanagement of major arterial hemorrhage as a complication of inflammatorypancreatic disease.
J Vasc Interv Radiol 2007; 18: 591-596.255. Hyun Gun Kim, Young Koog Cheon et al. Small sphincterotomy combinedwith endoscopic papillary large balloon dilation versus sphincterotomy. China:World J Gastroenterol. 2009; 15(34): 4298-4304.256. Ito K., Fujita N., Noda Y. et al. Relationship between post-ERCPpancreatitis and the change of serum amylase level after the procedure. World JGastroenterol 2007; 13: 3855–3860.257. Kapetanos D., Kokozidis G., Kinigopoulou P.
et al. The value of serumamylase and elastase measurements in the prediction of post-ERCP acutepancreatitis. Hepato-Gastroenterol 2007; 54: 556–560.258. Katsinelos P., Kountouras J., Paroutoglou G. et al. Intravenous Nacetylcysteine does not prevent post-ERCP pancreatitis. Gastrointest Endosc 2005;62: 105–111.259. Kaya E., Dervis A., Polat C.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
